Abstract
The neuroendocrine effects of haloperidol, usually reported as side effects of this drug when given in antipsychotic doses, have not been systematically investigated. In the present study five normal adult men were administered saline and two doses of haloperidol (0.25 mg, 0.5 mg) intramuscularly in a double-blind randomized block design. The anterior pituitary hormones GH, LH, FSH, and PRL were measured in blood samples taken every 20 min for several hours thereafter.
The low doses of haloperidol used have been shown by others to alter the human EEG; in our subjects these doses produced no objective or subjective clinical effects. There were no drug related changes in GH, LH, or FSH. PRL, however, showed a prompt, statistically significant, dose-related increase in plasma levels, with a return to baseline within 5h.
Haloperidol has strong dopamine-blocking effects, and the hypothalamic inhibitory mechanism for PRL release is believed to be dopamine-mediated. The results of this study suggest that haloperidol may have utility in low doses primarily for its hypothalamic neuroendocrine effects, and that dose-related PRL release may be a useful paradigm for comparing dopamine-blocking antipsychotic agents in humans.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andén, N.-E., Butcher, S. G., Corrodi, H., Fuxe, K., Ungerstedt, U.: Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Europ. J. Pharmacol.11, 303–314 (1970)
Apostolakis, M., Kapetanakis, S., Lazos, G., Madena-Pyrgaki, A.: Plasma prolactin activity in patients with galactorrhea after treatment with psychotropic drugs. In: Lactogenic hormones, G. E. W. Wolstenholme and J. Knight, eds., pp. 349–359. Edinburgh: Churchill Livingstone 1972
Beumont, P. J. V., Corker, C. S., Friesen, H. G., Kolakowska, T., Mandelbrote, B. M., Marshall, J., Murray, M. A. F., Wiles, D. H.: The effects of phenothiazines on endocrine function: II. Effects in men and post-menopausal women. Brit. J. Psychiat.124, 420–430 (1974b)
Beumont, P. J. V., Gelder, M. G., Friesen, H. G., Harris, G. W., MacKinnon, P. C. B., Mandelbrote, B. M., Wiles, D. H.: The effects of phenothiazines on endocrine function: I. Patients with inappropriate lactation and amenorrhea. Brit. J. Psychiat.124, 413–419 (1974a)
Beumont, P. J. V., Harris, G. W., Carr, P. J., Friesen, H. G., Kolakowska, T., MacKinnon, P. C. B., Mandelbrote, B. M., Wiles, D.: Some endocrine effects of phenothiazines: A preliminary report. J. Psychosom. Res.16, 297–304 (1972)
Bhattacharya, A. N., Dierschke, D. J., Yamaji, T., Knobil, E.: The pharmacologic blockade of the circhoral mode of LH secretion in the ovariectomized rhesus monkey. Endocrinology90, 778–786 (1972)
Boris, A., Milmore, J., Trmal, T.: Some effects of haloperidol on reproductive organs in the female rat. Endocrinology86, 429–431 (1970)
Bürki, H. R., Ruch, W., Asper, H.: Effects of clozapine, thioridazine, perlapine and haloperidol on the metabolism of the biogenic amines in the brain of the rat. Psychopharmacologia (Berl.)41, 27–33 (1975)
Christman, R. S., Weinstein, R. A., Larose, J. B.: Low-dose haloperidol as antiemetic treatment in gastrointestinal disorders: A double-blind study. Curr. Ther. Res.16, 1171–1176 (1974)
Clemens, J. A., Smalstig, E. B., Sawyer, B. D.: Antipsychotic drugs stimulate prolactin release. Psychopharmacologia (Berl.)40, 123–127 (1974)
Clement-Cormier, Y. C., Kebabian, J. W., Petzold, G. L., Greengard, P.: Dopamine-sensitive adenylate cyclase in mammalian brain: A possible site of action of antipsychotic drugs. Proc. natl. Acad. Sci. (Wash.).71, 1113–1117 (1974)
deWied, D., deJong, W.: Drug effects and hypothalamic-anterior pituitary function. Ann. Rev. Pharmacol.14, 389–412 (1974)
Dickerman, S., Clark, J., Dickerman, E., Meites, J.: Effects of haloperidol on serum and pituitary prolactin and on hypothalamic PIF in rats. Neuroendocrinology9, 332–340 (1972)
Dickerman, S., Kledzik, G., Gelato, M., Chen, H. J., Meites, J.: Effects of haloperidol on serum and pituitary prolactin, LH and FSH, and hypothalamic PIF and LRF. Neuroendocrinology15, 10–20 (1974)
Frantz, A. G., Kleinberg, D. L., Noel, G. L., Suh, H. K.: Effects of neuroleptics on the secretion of prolactin and growth hormone. In: Endocrinology, Proc. IV Int. Congr. Endocrinol., R. O. Scow, ed., pp. 144–149. Amsterdam: Excerpta Medica 1973
Ganong, W. F.: Pharmacological aspects of neuroendocrine integration. In: Topics in Neuroendocrinology, J. A. Kappers and I. P. Schade, eds. Progress in brain research, vol. 38, pp. 41–57. Amsterdam: Elsevier 1972
Goforth, E. G.: Gilles de la Tourette's syndrome: A 25-year follow-up study. J. nerv. ment. Dis.158, 306–309 (1974)
Kim, S., Sherman, L., Kolodny, H. D., Benjamin, F., Singh, A.: Attenuation by haloperidol of human serum growth hormone (HGH) response to insulin. Clin. Res.19, 718 (1971)
Kolodny, H. D., Sherman, L., Singh, A., Kim, S., Benjamin, F.: Acromegaly treated with chlorpromazine. New Engl. J. Med.284, 819–822 (1971)
Mishinsky, J., Khazen, K., Givant, Y., Dikstein, S., Sulman, F. G.: Mammotropic and neuroleptic effects of butyrophenones in the rat. Arch. int. Pharmacodyn.179, 94–105 (1969)
Odell, W. D., Rayford, P. L., Ross, G. T.: Simplified, partially automated method for radioimmunoassay of human thyroid stimulating, growth, luteinizing, and follicle stimulating hormones. J. Lab. clin. Med.70, 973–980 (1967b)
Odell, W. D., Ross, G. T., Rayford, P. L.: Radioimmunoassay for luteinizing hormone in human plasma or serum: Physiological studies. J. clin. Invest.46, 248–255 (1967a)
Ojeda, S. R., Harms, P. G., McCann, S. M.: Effect of blockade of dopaminergic receptors on prolactin and LH release: Median eminence and pituitary sites of action. Endocrinology94, 1650–1657 (1974)
Ondo, J. G.: Gamma-amino butyric acid effects on pituitary gonadotropin secretion. Science186, 738–739 (1974)
Pfeiffer, C. C., Goldstein, L., Murphree, H. B.: Effects of parenteral administration of haloperidol and chlorpromazine in man. I. Normal subjects: Quantitative EEG and subjective responses. J. clin. Pharmacol.8, 79–88 (1968)
Robbins, E. L., Nagel, J. D.: Haloperidol parenterally for treatment of vomiting and nausea from gastrointestinal disorders in a group of geriatric patients: Double-blind, placebo-controlled study. J. Amer. Geriat. Soc.23, 38–41 (1975)
Rubin, R. T., Gouin, P. R., Lubin, A., Poland, R. E., Pirke, K. M.: Nocturnal increase of plasma testosterone in men: Relation to gonadotropins and prolactin. J. clin. Endocr.40, 1027–1033 (1975)
Rubin, R. T., Poland, R. E., Tower, B. B.: Prolactin-related testosterone secretion in normal adult men. J. clin. Endocr.42, 112–116 (1976)
Rubin, R. T., Zir, L. M., Smith, R. A., Fagan, T., Adler, R.: Experience with the Vankirk-Sassin technique for serial blood sampling during sleep. Amer. J. EEG Technol.11, 17–18 (1971)
Schally, A. V., Arimura, A., Kastin, A. J.: Hypothalamic regulatory hormones. Science179, 341–350 (1973)
Shaar, C. J., Clemens, J. A.: The role of catecholamines in the release of anterior pituitary prolactin in vitro. Endocrinology95, 1202–1212 (1974)
Shani (Mishinsky), J., Morag, M.; Goldhaber, G., Yagil, R., Sulman, F. G.: Effect of haloperidol on serum prolactin and milk yield in the dairy ewe. J. Endocr.59, 363–364 (1973)
Sherman, L., Kim, S., Benjamin, F., Kolodny, H. D.: Effect of chlorpromazine on serum growth-hormone concentration in man. New Engl. J. Med.284, 72–74 (1971)
Sinha, Y. N., Selby, F., Lewis, U. J., VanderLaan, W. P.: A homologous radioimmunoassay for human prolactin. J. clin. Endocr.36, 509–516 (1973)
Sulman, F. G.: Hypothalamic control of lactation, pp. 120–132. Berlin-Heidelberg-New York: Springer 1970
Turkington, R. W.: Prolactin secretion in patients treated with various drugs. Arch. intern. Med.130, 349–354 (1972)
Upton, G. V., Corbin, A.: Hypothesis: Hypothalamic dysfunction and lipoartrophic diabetes. Yale J. Biol. Med.46, 314–323 (1973)
Winer, B. J.: Statistical principles in experimental design, pp. 302–303, 518–524. New York: McGraw-Hill 1971
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rubin, R.T., Poland, R.E., O'Connor, D. et al. Selective neuroendocrine effects of low-dose haloperidol in normal adult men. Psychopharmacology 47, 135–140 (1976). https://doi.org/10.1007/BF00735811
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00735811